OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Nectin cell adhesion molecule 4 regulates angiogenesis through Src signaling and serves as a novel therapeutic target in angiosarcoma
Yuka Tanaka, Maho Murata, Keiko Tanegashima, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 14
Yuka Tanaka, Maho Murata, Keiko Tanegashima, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 14
Showing 14 citing articles:
A multicenter study on TROP2 as a potential targeted therapy for extramammary Paget disease in Japan
Takamichi Ito, Yuka Tanaka, Dai Ogata, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Takamichi Ito, Yuka Tanaka, Dai Ogata, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Nectins and Nectin-like molecules drive vascular development and barrier function
Doryssa Hermans, Carla Rodriguez-Mogeda, Hannelore Kemps, et al.
Angiogenesis (2023) Vol. 26, Iss. 3, pp. 349-362
Closed Access | Times Cited: 14
Doryssa Hermans, Carla Rodriguez-Mogeda, Hannelore Kemps, et al.
Angiogenesis (2023) Vol. 26, Iss. 3, pp. 349-362
Closed Access | Times Cited: 14
Human epidermal growth factor receptor 3 serves as a novel therapeutic target for acral melanoma
Yuka Tanaka, Takamichi Ito, Yumiko Kaku‐Ito, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 11
Yuka Tanaka, Takamichi Ito, Yumiko Kaku‐Ito, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 11
NECTIN4‐targeted antibody–drug conjugate is a potential therapeutic option for extramammary Paget disease
Yuka Tanaka, Takamichi Ito, Maho Murata, et al.
Experimental Dermatology (2024) Vol. 33, Iss. 3
Open Access | Times Cited: 3
Yuka Tanaka, Takamichi Ito, Maho Murata, et al.
Experimental Dermatology (2024) Vol. 33, Iss. 3
Open Access | Times Cited: 3
Nectin-4: a Tumor Cell Target and Status of Inhibitor Development
Wafa Bouleftour, Paul Sargos, Nicolas Magné
Current Oncology Reports (2023) Vol. 25, Iss. 3, pp. 181-188
Closed Access | Times Cited: 7
Wafa Bouleftour, Paul Sargos, Nicolas Magné
Current Oncology Reports (2023) Vol. 25, Iss. 3, pp. 181-188
Closed Access | Times Cited: 7
Nail Apparatus Melanoma: Current Management and Future Perspectives
Takamichi Ito, Hiroki Hashimoto, Yumiko Kaku‐Ito, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 6, pp. 2203-2203
Open Access | Times Cited: 7
Takamichi Ito, Hiroki Hashimoto, Yumiko Kaku‐Ito, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 6, pp. 2203-2203
Open Access | Times Cited: 7
KS-EMPD-1: a novel cell line of primary extramammary Paget’s disease
Takamichi Ito, Yuka Tanaka, Toshio Ichiki, et al.
Human Cell (2023) Vol. 36, Iss. 5, pp. 1813-1829
Closed Access | Times Cited: 5
Takamichi Ito, Yuka Tanaka, Toshio Ichiki, et al.
Human Cell (2023) Vol. 36, Iss. 5, pp. 1813-1829
Closed Access | Times Cited: 5
The Antiviral Role of Nectin4 Against Red Spotted Grouper Nervous Necrosis Virus Infection in Japanese Medaka, Oryzias Latipes
Ronggui Dai, Bilin Xia, Mengyang Wang, et al.
(2024)
Closed Access
Ronggui Dai, Bilin Xia, Mengyang Wang, et al.
(2024)
Closed Access
Japanese medaka (Oryzias latipes) Nectin4 plays an important role against red spotted grouper nervous necrosis virus infection
Ronggui Dai, Bilin Xia, Mengyang Wang, et al.
Fish & Shellfish Immunology (2024) Vol. 150, pp. 109650-109650
Closed Access
Ronggui Dai, Bilin Xia, Mengyang Wang, et al.
Fish & Shellfish Immunology (2024) Vol. 150, pp. 109650-109650
Closed Access
Keiko Tanegashima, Yuka Tanaka, Takamichi Ito, et al.
Experimental Dermatology (2024) Vol. 33, Iss. 10
Open Access
Mechanisms of resistance of antibody-drug conjugates—Obstacles to overcome
Yanitsa Davidkova, Milan Jagurinoski, Margarita Guenova
Elsevier eBooks (2024), pp. 257-273
Closed Access
Yanitsa Davidkova, Milan Jagurinoski, Margarita Guenova
Elsevier eBooks (2024), pp. 257-273
Closed Access
Targeted Therapeutic Strategies for Nectin-4 in Breast Cancer: Recent Advances and Future Prospects
Yufei Wang, Guangliang Li, Han-Ying Wang, et al.
The Breast (2024) Vol. 79, pp. 103838-103838
Open Access
Yufei Wang, Guangliang Li, Han-Ying Wang, et al.
The Breast (2024) Vol. 79, pp. 103838-103838
Open Access
Clinical and Histopathological Characterization of Enfortumab vedotin-Associated Cutaneous Toxicities: A Case Series
Ista A. Egbeto, Evangelia Vlachou, Daniela Barata Herrera, et al.
JAAD Case Reports (2024) Vol. 57, pp. 114-121
Open Access
Ista A. Egbeto, Evangelia Vlachou, Daniela Barata Herrera, et al.
JAAD Case Reports (2024) Vol. 57, pp. 114-121
Open Access
Nectin4 is a potential therapeutic target for asthma
Pureun‐Haneul Lee, Seon Muk Choi, Min Hyeok An, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 3
Pureun‐Haneul Lee, Seon Muk Choi, Min Hyeok An, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 3
Human epidermal growth factor receptor 3 serves as a novel therapeutic target for acral melanoma
Yuka Tanaka, Takamichi Ito, Yumiko Kaku‐Ito, et al.
Research Square (Research Square) (2022)
Open Access
Yuka Tanaka, Takamichi Ito, Yumiko Kaku‐Ito, et al.
Research Square (Research Square) (2022)
Open Access
